48
In band
Moving averages
SMA 200$1.25-20.33%
Company profile
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$98.90M
P/E ratioNone
EPS$-0.17
Beta1.776
Dividend yield0.00%
52-week high$3.83
52-week low$0.55
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 79
VRTX
Vertex Pharmaceuticals Inc
RSI 67
CRSP
CRISPR Therapeutics AG
RSI 67
IOVA
Iovance Biotherapeutics Inc
RSI 72
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 59
MRNA
Moderna Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 48
SRPT
Sarepta Therapeutics Inc
RSI 59
EDIT
Editas Medicine Inc
RSI 57
NVAX
Novavax Inc
RSI 63
RSI alerts for CGTX
Get an email the moment Cognition Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 14 August 2026 at 8:11 AM EDT